항결핵제 치료 시작 후 급성호흡부전이 발생한 폐결핵 환자의 특징
Development of Acute Respiratory Failure on Initiation of Anti-Tuberculosis Medication in Patients with Pulmonary Tuberculosis: Clinical and Radiologic Features of 8 Patients and Literature Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Acute respiratory failure can occur paradoxically on initiation of anti-tuberculosis (TB) treatment in patients with pulmonary TB. This study is aimed to analyze the clinical features of anti-TB treatment induced acute respiratory failure. Methods: We reviewed the clinical and radiological characteristics of 8 patients with pulmonary tuberculosis (5 men and 3 women; mean age, 55 ± 15.5 years) who developed acute respiratory failure following initiation of anti- TB medication and thus required mechanical ventilation (MV) in the intensive care unit (ICU). Results: The interval between initiation of anti-TB medication and development of MV-requiring acute respiratory failure was 2－14 days (mean, 4.4 ± 4.39 days), and the duration of MV was 1－18 days (mean, 7.1 ± 7.03 days). At admission, body temperature and serum levels of lactate dehydrogenase and C-reactive protein were increased. Serum levels of protein, albumin and creatinine were 5.8 ± 0.98, 2.3 ± 0.5 and 1.8 ± 2.58 mg/ml, respectively. Radiographs characterized both lung involvements in all patients. Consolidation with the associated nodule was noted in 7 patients, ground glass opacity in 2, and cavitary lesion in 4. Micronodular lesion in the lungs, suggesting miliary tuberculosis lesion, was noted in 1 patient. At ICU admissions, the ranges of the APACHE II and SOFA scores were 17－38 (mean, 28.2 ± 7.26) and 6－14 (mean, 10.1 ± 2.74). The mean lung injury score was 2.8 ± 0.5. Overall, 6 patients died owing to septic shock and multiorgan failure. Conclusions: On initiation of treatment for pulmonary TB, acute respiratory failure can paradoxically occur in patients with extensive lung parenchymal involvement and high mortality.
Abstract
Background: Acute respiratory failure can occur paradoxically on initiation of anti-tuberculosis (TB) treatment in patients with pulmonary TB. This study is aimed to analyze the clinical features of anti-TB treatment induced acute respiratory failure. Methods: We reviewed the clinical and radiological characteristics of 8 patients with pulmonary tuberculosis (5 men and 3 women; mean age, 55 ± 15.5 years) who developed acute respiratory failure following initiation of anti- TB medication and thus required mechanical ventilation (MV) in the intensive care unit (ICU). Results: The interval between initiation of anti-TB medication and development of MV-requiring acute respiratory failure was 2－14 days (mean, 4.4 ± 4.39 days), and the duration of MV was 1－18 days (mean, 7.1 ± 7.03 days). At admission, body temperature and serum levels of lactate dehydrogenase and C-reactive protein were increased. Serum levels of protein, albumin and creatinine were 5.8 ± 0.98, 2.3 ± 0.5 and 1.8 ± 2.58 mg/ml, respectively. Radiographs characterized both lung involvements in all patients. Consolidation with the associated nodule was noted in 7 patients, ground glass opacity in 2, and cavitary lesion in 4. Micronodular lesion in the lungs, suggesting miliary tuberculosis lesion, was noted in 1 patient. At ICU admissions, the ranges of the APACHE II and SOFA scores were 17－38 (mean, 28.2 ± 7.26) and 6－14 (mean, 10.1 ± 2.74). The mean lung injury score was 2.8 ± 0.5. Overall, 6 patients died owing to septic shock and multiorgan failure. Conclusions: On initiation of treatment for pulmonary TB, acute respiratory failure can paradoxically occur in patients with extensive lung parenchymal involvement and high mortality.
참고문헌 (16)
- Diagnostic Standards and Classification of Tuberculosis in Adults and Children, "This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999", Am J Respir Crit Care Med, 161, pp.1376~1395 (2000)
- Smith H, "Paradoxical responses during the chemotherapy of tuberculosis", J Infect, 15, pp.1~3 (1987)
- Breen RA, "Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection", Thorax, 59, pp.704~707 (2004)
- Agarwal MK, "Respiratory failure in pulmonary tuberculosis", Chest, 72, pp.605~609 (1977)
- Ellis ME, "Cause of death in patients admitted to hospital for pulmonary tuberculosis", Lancet, 1, pp.665~667 (1983)
- Onwubalili JK, "Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature", Q J Med, 59, pp.599~610 (1986)
- Subhash HS, "Acute respiratory distress syndrome as a paradoxical response to anti-tuberculous and anti-retroviral therapy", Indian J Tuberc, 53, pp.157~160 (2006)
- Knaus WA, "APACHE II: a severity of disease classification system", Crit Care Med, 13, pp.818~829 (1985)
- Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction", failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, 1996, pp.22, 707~710
- Raghavendran K, "Definition of ALI", ARDS, 2011, pp.27, 429~437
- Al-Majed SA, "Study of paradoxical response to chemotherapy in tuberculous pleural effusion", Respir Med, 90, pp.211~214 (1996)
- Cheng VC, "Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients", Eur J Clin Microbiol Infect Dis, 21, pp.803~809 (2002)
- Akira M, "Clinical and high-resolution computed tomographic findings in five patients with pulmonary tuberculosis who developed respiratory failure following chemotherapy", Clin Radiol, 56, pp.550~555 (2001)
- Reddy RC, "Sepsisinduced immunosuppression: from bad to worse", Immunol Res, 24, pp.273~287 (2001)
- Cheng SL, "Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis", Int J Tuberc Lung Dis, 11, pp.1290~1295 (2007)
- McAdams HP, "Radiologic manifestations of pulmonary tuberculosis", Radiol Clin North Am, 33, pp.655~678 (1995)